Related Experiment Video
Updated: Aug 10, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Dopamine receptors in the central nervous system
Federation Proceedings
|February 1, 1978
Summary
Researchers studied dopamine receptors using radioligands like [3H]apomorphine. Findings suggest receptor sensitization and altered receptor numbers following drug exposure, impacting central nervous system function.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Dopamine receptors are crucial in the central nervous system.
- Studying these receptors is key to understanding neurological functions and drug actions.
- Radioligand binding assays are standard methods for receptor characterization.
Purpose of the Study:
- To investigate dopamine receptor binding characteristics using various radioligands.
- To assess the reliability of [3H]apomorphine as a dopamine receptor ligand.
- To explore dopamine receptor regulation and conformational states.
Main Methods:
- Measuring specific binding of radiolabeled ligands ([3H]dopamine, [3H]haloperidol, d-[3H]LSD, [3H]dihydroergocryptine, [3H]apomorphine).
- Utilizing stereoselective blockade with (+)-butaclamol.
- Assessing neuroleptic inhibition of [3H]haloperidol binding.
- Analyzing competition binding with dopamine agonists for [3H]apomorphine.
- Investigating effects of prolonged dopamine exposure and chronic haloperidol treatment on receptor binding.
Main Results:
- [3H]apomorphine demonstrated slow desorbing kinetics, identifying it as a reliable dopamine receptor ligand.
- Dopamine agonists' competition for [3H]apomorphine binding correlated with their ability to stimulate striatal adenylate cyclase.
- Structure-activity analysis with [3H]apomorphine confirmed the beta rotamer of dopamine as the active conformation.
- In vitro dopamine exposure induced increased binding of [3H]apomorphine and [3H]haloperidol, suggesting receptor sensitization.
- Chronic haloperidol treatment in rats increased striatal dopamine/neuroleptic receptors but decreased pituitary receptors.
Conclusions:
- [3H]apomorphine is a valuable radioligand for studying dopamine receptors and their agonists.
- Dopamine receptor conformation and regulation can be modulated by ligand binding and chronic drug exposure.
- Differential effects of chronic haloperidol on striatal versus pituitary dopamine receptors highlight regional specificity.
Related Concept Videos
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:31Neurotransmitters
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.